{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T04:12:52Z","timestamp":1789186372771,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K01DA047142"],"award-info":[{"award-number":["K01DA047142"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"DOI":"10.1186\/s12913-025-13813-3","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T12:06:20Z","timestamp":1765281980000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Implementation challenges and opportunities in decentralized methadone service delivery"],"prefix":"10.1186","volume":"26","author":[{"given":"Iddi Haruna","family":"Nkya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feaven","family":"Gebrezgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adela","family":"Luswetula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessie","family":"Mbwambo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haneefa T.","family":"Saleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,9]]},"reference":[{"key":"13813_CR1","unstructured":"WHO Guidelines Approved by the Guidelines Review Committee. Guidelines for the Psychosocially Assisted Pharmacological Treatment of Opioid Dependence. Geneva: World Health Organization Copyright \u00a9; 2009."},{"issue":"1","key":"13813_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13722-023-00374-1","volume":"18","author":"D Knight","year":"2023","unstructured":"Knight D, Nkya IH, West NS, Yang C, Kidorf M, Latkin C, et al. Economic, social, and clinic influences on opioid treatment program retention in Dar Es Salaam, tanzania: a qualitative study. Addict Sci Clin Pract. 2023;18(1):19.","journal-title":"Addict Sci Clin Pract"},{"issue":"1","key":"13813_CR3","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13722-024-00468-4","volume":"19","author":"P Mudiope","year":"2024","unstructured":"Mudiope P, Mutamba BB, Komuhangi L, Nangendo J, Alamo S, Mathers B, et al. Retention of people who inject drugs enrolled in a \u2018medications for opioid use disorder\u2019 (MOUD) programme in Uganda. Addict Sci Clin Pract. 2024;19(1):39.","journal-title":"Addict Sci Clin Pract"},{"issue":"1","key":"13813_CR4","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13722-022-00352-z","volume":"17","author":"SK Kiburi","year":"2022","unstructured":"Kiburi SK, Mwangi J, Maina G. Exploring the experiences of clients receiving opioid use disorder treatment at a methadone clinic in kenya: a qualitative study. Addict Sci Clin Pract. 2022;17(1):71.","journal-title":"Addict Sci Clin Pract"},{"issue":"9","key":"13813_CR5","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1080\/10826084.2021.1922450","volume":"56","author":"J Ndimbii","year":"2021","unstructured":"Ndimbii J, Guise A, Igonya EK, Owiti F, Strathdee S, Rhodes T. Qualitative analysis of community support to methadone access in Kenya. Subst Use Misuse. 2021;56(9):1312\u20139.","journal-title":"Subst Use Misuse"},{"key":"13813_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12954-015-0063-0","volume":"12","author":"BX Tran","year":"2015","unstructured":"Tran BX, Nguyen LH, Phan HT, Nguyen LK, Latkin CA. Preference of methadone maintenance patients for the integrative and decentralized service delivery models in Vietnam. Harm Reduct J. 2015;12:29.","journal-title":"Harm Reduct J"},{"issue":"4","key":"13813_CR7","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1111\/dar.13613","volume":"42","author":"DB Nguyen","year":"2023","unstructured":"Nguyen DB, Nguyen TT, Lin C, Dinh TTT, Le GM, Li L. Challenges of methadone maintenance treatment decentralisation from Vietnamese primary care providers\u2019 perspectives. Drug Alcohol Rev. 2023;42(4):803\u201314.","journal-title":"Drug Alcohol Rev"},{"key":"13813_CR8","unstructured":"Ba I, Desclaux A, Diop M, Ndiaye I, Thiam MH. Ensuring continuity of care at the time of COVID-19: challenges for the Dakar integrated support center for addictions. Med Trop Sante Int. 2021;1(1)."},{"issue":"4","key":"13813_CR9","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1097\/ADM.0000000000000310","volume":"11","author":"JR Brooklyn","year":"2017","unstructured":"Brooklyn JR, Sigmon SC. Vermont Hub-and-Spoke model of care for opioid use disorder: Development, Implementation, and impact. J Addict Med. 2017;11(4):286\u201392.","journal-title":"J Addict Med"},{"key":"13813_CR10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jsat.2019.07.007","volume":"108","author":"S Reif","year":"2020","unstructured":"Reif S, Brolin MF, Stewart MT, Fuchs TJ, Speaker E, Mazel SB. The Washington state hub and spoke model to increase access to medication treatment for opioid use disorders. J Subst Abuse Treat. 2020;108:33\u20139.","journal-title":"J Subst Abuse Treat"},{"key":"13813_CR11","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jsat.2019.05.005","volume":"108","author":"EL Winstanley","year":"2020","unstructured":"Winstanley EL, Lander LR, Berry JH, Mahoney JJ 3rd, Zheng W, Herschler J, et al. West virginia\u2019s model of buprenorphine expansion: preliminary results. J Subst Abuse Treat. 2020;108:40\u20137.","journal-title":"J Subst Abuse Treat"},{"key":"13813_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2018.04.029","volume":"191","author":"G Gauthier","year":"2018","unstructured":"Gauthier G, Eibl JK, Marsh DC. Improved treatment-retention for patients receiving methadone dosing within the clinic providing physician and other health services (onsite) versus dosing at community (offsite) pharmacies. Drug Alcohol Depend. 2018;191:1\u20135.","journal-title":"Drug Alcohol Depend"},{"key":"13813_CR13","doi-asserted-by":"publisher","first-page":"104487","DOI":"10.1016\/j.drugpo.2024.104487","volume":"129","author":"H Englander","year":"2024","unstructured":"Englander H, Chappuy M, Krawczyck N, Bratberg J, Potee R, Jauffret-Roustide M, et al. Comparing methadone policy and practice in France and the US: implications for US policy reform. Int J Drug Policy. 2024;129:104487.","journal-title":"Int J Drug Policy"},{"key":"13813_CR14","doi-asserted-by":"publisher","first-page":"209086","DOI":"10.1016\/j.josat.2023.209086","volume":"152","author":"V Panwala","year":"2023","unstructured":"Panwala V, Joudrey P, Kowalski M, Bach P, Amram O. Changes to methadone maintenance therapy in the united States, Canada, and Australia during the COVID-19 pandemic: A narrative review. J Subst Use Addict Treat. 2023;152:209086.","journal-title":"J Subst Use Addict Treat"},{"issue":"2","key":"13813_CR15","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1007\/s11096-019-00790-x","volume":"41","author":"R Yadav","year":"2019","unstructured":"Yadav R, Taylor D, Taylor G, Scott J. Community pharmacists\u2019 role in preventing opioid substitution therapy-related deaths: a qualitative investigation into current UK practice. Int J Clin Pharm. 2019;41(2):470\u20137.","journal-title":"Int J Clin Pharm"},{"issue":"4","key":"13813_CR16","doi-asserted-by":"publisher","first-page":"210","DOI":"10.4066\/AMJ.2011.706","volume":"4","author":"BB Chaar","year":"2011","unstructured":"Chaar BB, Hanrahan JR, Day C. Provision of opioid substitution therapy services in Australian pharmacies. Australas Med J. 2011;4(4):210\u20136.","journal-title":"Australas Med J"},{"issue":"1","key":"13813_CR17","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.4102\/phcfm.v14i1.3386","volume":"14","author":"U Bhoora","year":"2022","unstructured":"Bhoora U, Gloeck NR, Scheibe A. Managing acute opioid withdrawal with Tramadol during COVID-19 lockdown in a peri-urban setting. Afr J Prim Health Care Fam Med. 2022;14(1):e1\u20139.","journal-title":"Afr J Prim Health Care Fam Med"},{"key":"13813_CR18","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/978-3-319-63522-4_3","volume-title":"Structural dynamics of HIV. Social aspects of HIV","author":"J Mbwambo","year":"2018","unstructured":"Mbwambo J, Saleem HT, Kaduri P, Lambdin B, McCurdy S. Addressing the micro- and macro-environmental vulnerabilities to HIV of people who inject drugs in tanzania: A case study of the muhimbili medication-assisted treatment clinic. In: Kerrigan D, Barrington C, editors. Structural dynamics of HIV. Social aspects of HIV. 1 ed. Cham, Switzerland: Springer International Publishing; 2018. pp. 45\u201363.","edition":"1"},{"key":"13813_CR19","unstructured":"Drug Control and Enforcement Act. 2015."},{"issue":"1","key":"13813_CR20","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1080\/09540121.2022.2032575","volume":"35","author":"HT Saleem","year":"2023","unstructured":"Saleem HT, Knight D, Yang C, Kidorf M, Latkin C, Nkya IH, HIV, Stigma. HIV status disclosure, and ART adherence in the context of an integrated opioid use disorder and HIV treatment setting in Dar es Salaam, Tanzania. AIDS Care. 2023;35(1):91\u20134.","journal-title":"AIDS Care"},{"issue":"1","key":"13813_CR21","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1177\/1525822X05279903","volume":"18","author":"G Guest","year":"2006","unstructured":"Guest G, Bunce A, Johnson L. How many interviews are enough? An experiment with data saturation and variability. Field Methods. 2006;18(1):59\u201382.","journal-title":"Field Methods"},{"issue":"1","key":"13813_CR22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/1525822X16639015","volume":"29","author":"G Guest","year":"2016","unstructured":"Guest G, Namey E, McKenna K. How many focus groups are enough? Building an evidence base for nonprobability sample sizes. Field Methods. 2016;29(1):3\u201322.","journal-title":"Field Methods"},{"issue":"1","key":"13813_CR23","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13012-022-01245-0","volume":"17","author":"LJ Damschroder","year":"2022","unstructured":"Damschroder LJ, Reardon CM, Widerquist MAO, Lowery J. The updated consolidated framework for implementation research based on user feedback. Implement Sci. 2022;17(1):75.","journal-title":"Implement Sci"},{"key":"13813_CR24","doi-asserted-by":"publisher","first-page":"107968","DOI":"10.1016\/j.drugalcdep.2020.107968","volume":"211","author":"PJ Joudrey","year":"2020","unstructured":"Joudrey PJ, Chadi N, Roy P, Morford KL, Bach P, Kimmel S, et al. Pharmacy-based methadone dispensing and drive time to methadone treatment in five States within the united states: A cross-sectional study. Drug Alcohol Depend. 2020;211:107968.","journal-title":"Drug Alcohol Depend"},{"key":"13813_CR25","doi-asserted-by":"publisher","first-page":"100067","DOI":"10.1016\/j.dadr.2022.100067","volume":"3","author":"RK Brooner","year":"2022","unstructured":"Brooner RK, Stoller KB, Patel P, Wu L-T, Yan H, Kidorf M. Opioid treatment program prescribing of methadone with community pharmacy dispensing: pilot study of feasibility and acceptability. Drug Alcohol Depend Rep. 2022;3:100067.","journal-title":"Drug Alcohol Depend Rep"},{"issue":"1","key":"13813_CR26","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13722-023-00399-6","volume":"18","author":"L-T Wu","year":"2023","unstructured":"Wu L-T, John WS, Mannelli P, Morse ED, Anderson A, Schwartz RP. Patient perspectives on community pharmacy administered and dispensing of methadone treatment for opioid use disorder: a qualitative study in the U.S. Addict Sci Clin Pract. 2023;18(1):45.","journal-title":"Addict Sci Clin Pract"},{"issue":"1","key":"13813_CR27","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12875-018-0792-8","volume":"19","author":"MC Van Hout","year":"2018","unstructured":"Van Hout MC, Crowley D, McBride A, Delargy I. Optimising treatment in opioid dependency in primary care: results from a National key stakeholder and expert focus group in Ireland. BMC Fam Pract. 2018;19(1):103.","journal-title":"BMC Fam Pract"},{"issue":"1","key":"13813_CR28","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1071\/HC23032","volume":"15","author":"DS Goeieman","year":"2023","unstructured":"Goeieman DS, Nonyane DS, Nzaumvila DK, van Anse MNS. Retention of service users on opioid substitution therapy in the City of Tshwane, South Africa. Afr J Prim Health Care Fam Med. 2023;15(1):e1\u201310.","journal-title":"Afr J Prim Health Care Fam Med"},{"issue":"1","key":"13813_CR29","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12954-020-00368-1","volume":"17","author":"M Marks","year":"2020","unstructured":"Marks M, Scheibe A, Shelly S. High retention in an opioid agonist therapy project in Durban, South africa: the role of best practice and social cohesion. Harm Reduct J. 2020;17(1):25.","journal-title":"Harm Reduct J"},{"key":"13813_CR30","first-page":"117822182110397","volume":"15","author":"B Green","year":"2021","unstructured":"Green B, Rhubart DC, Filteau MR. Barriers for implementing the hub and spoke model to expand medication for opioid use disorder: A case study of Montana. Subst Abuse: Res Treat. 2021;15:11782218211039781.","journal-title":"Subst Abuse: Res Treat"},{"issue":"1","key":"13813_CR31","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12884-023-06172-6","volume":"24","author":"L Gilmour","year":"2024","unstructured":"Gilmour L, Honeybul L, Lewis S, Smith E, Cheyne H, Aladangady N, et al. Scoping review: mapping clinical guidelines and policy documents that address the needs of women who are dependent on drugs during the perinatal period. BMC Pregnancy Childbirth. 2024;24(1):84.","journal-title":"BMC Pregnancy Childbirth"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-025-13813-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-025-13813-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-025-13813-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T14:26:46Z","timestamp":1768314406000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12913-025-13813-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,9]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13813"],"URL":"https:\/\/doi.org\/10.1186\/s12913-025-13813-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7565402\/v1","asserted-by":"object"}]},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,9]]},"assertion":[{"value":"8 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures followed were in accordance with the ethical standards of the Responsible Committee on Human Experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000. The study was reviewed and approved by the Senate Research and Publications Committee at the Muhimbili University of Health and Allied Sciences (DA.282\/298\/01.C\/), the National Health Research Ethics Review Committee at the National Institute for Medical Research in Tanzania (NIMR\/HQ\/R.8a\/Vol. IX\/3334), and the Institutional Review Board at the Johns Hopkins University Bloomberg School of Public Health (IRB00009747). All participants provided oral informed consent prior to study participation, which was approved by the Senate Research and Publications Committee at the Muhimbili University of Health and Allied Sciences, the National Health Research Ethics Review Committee at the National Institute for Medical Research in Tanzania, and the Institutional Review Board at the Johns Hopkins University Bloomberg School of Public Health. Oral consent was obtained because the study was low risk and written consent would be the only record with the names of the people participating in the study and could have potentially placed participants at risk with local law enforcement, given the illegality of heroin use.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"N\/A.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"61"}}